Maintenance of Investigator's Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis

• Main Authors: Lawrence F. Eichenfield (Author), Linda F. Stein Gold (Author), Charles Lynde (Author), Lyn Guenther (Author), Shoshana Greenberger (Author), Chia-Yu Chu (Author), Zara Ghodsi (Author), Bonnie Vlahos (Author), Paul Sanders (Author), Amy Cha (Author), Juliana M. Canosa (Author)
• Formato: Libro
• Publicado: Adis, Springer Healthcare, 2024-03-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Abstract Introduction Treatments for atopic dermatitis (AD) often fail to achieve lasting disease control. In the CrisADe CONTROL phase III study (ClinicalTrials.gov: NCT04040192), participants aged ≥ 3 months with mild to moderate AD treated with once-daily (QD) crisaborole, following initial treat...